StartAngels Network

Hylomorph AG is a MedTech company based in Zurich, Switzerland, focused on developing innovative solutions to address fibrotic encapsulation in implantable medical devices. Founded in 2014, the company specializes in a cellulose film designed to prevent the formation and adhesion of fibrotic tissue, thereby reducing the risk of implant failure. This technology is particularly applicable in cardiac and plastic surgery, where it aids surgeons during the implantation of devices such as pacemakers and neurostimulators. Hylomorph combines advanced biotechnology and surface micro-engineering to enhance the interaction between biological tissues and medical implants, ultimately aiming to improve patient outcomes and the overall quality of healthcare.

Medyria AG is a Swiss medtech company based in Winterthur, specializing in sensor-based catheter navigation and sensing systems for cardiovascular procedures. Founded in 2012, the company offers a range of innovative products, including a catheter positioning system designed for X-ray and C-dye free minimally invasive interventions, as well as Flowcath, which measures blood flow. Their Trackcath technology processes flow data to enhance catheter tracking, while their OEM flow sensor utilizes proprietary technology for measuring blood and physiological fluid flow. Medyria aims to enhance the safety and effectiveness of endovascular procedures, ultimately improving patient outcomes and reducing procedural complications and costs.

Hylomorph AG is a MedTech company based in Zurich, Switzerland, focused on developing innovative solutions to address fibrotic encapsulation in implantable medical devices. Founded in 2014, the company specializes in a cellulose film designed to prevent the formation and adhesion of fibrotic tissue, thereby reducing the risk of implant failure. This technology is particularly applicable in cardiac and plastic surgery, where it aids surgeons during the implantation of devices such as pacemakers and neurostimulators. Hylomorph combines advanced biotechnology and surface micro-engineering to enhance the interaction between biological tissues and medical implants, ultimately aiming to improve patient outcomes and the overall quality of healthcare.

CompPair Technologies Ltd. specializes in the design and development of healable structural composites aimed at extending the lifespan of composite materials. Originating from extensive research at the Laboratory for Processing of Advanced Composites at EPFL in Lausanne, Switzerland, the company has created innovative smart prepreg materials that address damage issues in various industries, including aerospace, automotive, wind energy, and sports. These advanced materials, composed of robust fibers embedded in a matrix, facilitate repeated damage healing and simplify recycling at the end of their life cycle. By offering solutions that reduce maintenance costs and enhance durability, CompPair contributes to greater sustainability within the composites industry. Founded in 2019, the company continues to leverage its research background to deliver effective and environmentally friendly products.

CompPair Technologies Ltd. specializes in the design and development of healable structural composites aimed at extending the lifespan of composite materials. Originating from extensive research at the Laboratory for Processing of Advanced Composites at EPFL in Lausanne, Switzerland, the company has created innovative smart prepreg materials that address damage issues in various industries, including aerospace, automotive, wind energy, and sports. These advanced materials, composed of robust fibers embedded in a matrix, facilitate repeated damage healing and simplify recycling at the end of their life cycle. By offering solutions that reduce maintenance costs and enhance durability, CompPair contributes to greater sustainability within the composites industry. Founded in 2019, the company continues to leverage its research background to deliver effective and environmentally friendly products.

Typewise AG is a Swiss technology company based in Binningen, founded in 2019. It develops a keyboard app for iOS and Android that supports over 30 languages and allows for simultaneous use of multiple languages, including a custom dictionary that adapts to user input. The app has been installed nearly 2 million times and has received the CES Innovation Award for two consecutive years. In addition to the keyboard app, Typewise offers an AI Writing Assistant that enhances written communication for businesses, increasing productivity by 2 to 3 times. This tool is particularly beneficial for customer service and sales teams. Furthermore, Typewise provides a Text Prediction API for developers, enabling them to integrate advanced text prediction capabilities into their applications. Overall, Typewise aims to improve efficiency and accuracy in communication through its innovative products.

Peripal AG is a medical device company based in Zurich, Switzerland, founded in 2015. It specializes in developing and commercializing patient aids for home care patients undergoing dialysis, particularly focusing on Peritoneal dialysis. Notable products include PeriSafe, a patient assist device designed to facilitate the Peritoneal dialysis process, and PERiPLEX, a diagnostic tool for detecting infections associated with this treatment. The company’s primary innovation, the Peripal System, enhances the manual connection of dialysis tubings, addressing the complexities and risks associated with traditional methods. By simplifying the connection process, Peripal aims to empower more patients to perform their dialysis at home, thereby alleviating anxiety for healthcare providers and reducing overall healthcare costs.

Hylomorph AG is a MedTech company based in Zurich, Switzerland, focused on developing innovative solutions to address fibrotic encapsulation in implantable medical devices. Founded in 2014, the company specializes in a cellulose film designed to prevent the formation and adhesion of fibrotic tissue, thereby reducing the risk of implant failure. This technology is particularly applicable in cardiac and plastic surgery, where it aids surgeons during the implantation of devices such as pacemakers and neurostimulators. Hylomorph combines advanced biotechnology and surface micro-engineering to enhance the interaction between biological tissues and medical implants, ultimately aiming to improve patient outcomes and the overall quality of healthcare.

Peripal AG is a medical device company based in Zurich, Switzerland, founded in 2015. It specializes in developing and commercializing patient aids for home care patients undergoing dialysis, particularly focusing on Peritoneal dialysis. Notable products include PeriSafe, a patient assist device designed to facilitate the Peritoneal dialysis process, and PERiPLEX, a diagnostic tool for detecting infections associated with this treatment. The company’s primary innovation, the Peripal System, enhances the manual connection of dialysis tubings, addressing the complexities and risks associated with traditional methods. By simplifying the connection process, Peripal aims to empower more patients to perform their dialysis at home, thereby alleviating anxiety for healthcare providers and reducing overall healthcare costs.

Advanced Osteotomy Tools AG is a Swiss company focused on developing innovative medical devices for osteotomy, a surgical procedure that involves cutting and reshaping bones. Established in 2010 and based in Basel, the company specializes in a computer-assisted and robot-guided laser osteotome device designed for precise functional geometrical bone cuts. This technology is applicable in cranio-maxillofacial interventions and various complex surgical procedures. Advanced Osteotomy Tools AG originated from the University Hospital and the University of Basel, transitioning into a privately owned entity in 2011, with its first funding secured in 2012. The company's mission is to advance bone surgery by utilizing laser technology, robotics, and navigation systems for a contact-free surgical experience.

Diviac is a prominent online travel agency specializing in scuba diving, founded in December 2012 in Switzerland. The platform aims to inspire divers to explore more destinations and contribute to ocean conservation. Diviac offers an extensive selection of dive holidays, surpassing competitors in both variety and accessibility. It caters to both group and individual travelers, combining a user-friendly online booking experience with personalized guidance from a global team of scuba travel experts. Additionally, Diviac is committed to sustainability, having launched Diviac Eco Travel, which provides divers with opportunities to engage in vacations that positively impact ocean conservation efforts.

Medyria AG is a Swiss medtech company based in Winterthur, specializing in sensor-based catheter navigation and sensing systems for cardiovascular procedures. Founded in 2012, the company offers a range of innovative products, including a catheter positioning system designed for X-ray and C-dye free minimally invasive interventions, as well as Flowcath, which measures blood flow. Their Trackcath technology processes flow data to enhance catheter tracking, while their OEM flow sensor utilizes proprietary technology for measuring blood and physiological fluid flow. Medyria aims to enhance the safety and effectiveness of endovascular procedures, ultimately improving patient outcomes and reducing procedural complications and costs.

Bluetector AG, founded in 2012 and based in Root, Switzerland, specializes in manufacturing wastewater treatment machinery, particularly focused on the treatment of manure and biogas digestate. The company offers innovative containerized filtering systems that biologically purify wastewater, providing a cost-effective alternative to traditional disposal methods. By converting excess manure into clean water, Bluetector addresses the challenges faced by farmers who often have too much manure and insufficient land for spreading. This technology significantly reduces transportation costs associated with manure disposal, enabling farmers to manage their waste sustainably and economically. Additionally, Bluetector constructs and renovates municipal wastewater treatment plants, further contributing to effective wastewater management solutions.

Creoptix AG is a Swiss company specializing in the development of advanced optical instruments and consumables for label-free analysis of molecular interactions, primarily serving the drug discovery sector. Founded in 2009 and headquartered in Wädenswil, with an additional office in the Boston area, Creoptix focuses on next-generation bioanalytical tools that enhance research capabilities in both industry and academia. Its flagship product, the Creoptix® WAVEsystem, utilizes proprietary Grating-Coupled Interferometry (GCI) technology to provide high sensitivity and resolution for studying real-time biological interactions involving various molecules, including small molecules, peptides, and membrane proteins, even in complex biofluids like serum or plasma. The company also offers versatile sensors and integrated software that streamline assay setup and data evaluation, making it easier for researchers to conduct molecular interaction studies.

Leman Micro Devices SA, founded in 2013 and based in Lausanne, Switzerland, specializes in innovative health monitoring technology for smartphones. The company has developed the V-Sensor, a pioneering miniature device that accurately measures five vital signs: blood pressure, blood oxygen (SpO2), respiration rate, pulse rate, and body temperature. This device operates without cuffs or the need for calibration, delivering results on-screen in under one minute through LMD’s e-Checkup app. Launched at CES 2021, the V-Sensor is designed to provide users with a convenient way to monitor their health using smartphones and wearable technology.

Credentis is a Swiss company founded in 2010 and based in Windisch, Aargau, specializing in the research, development, production, and distribution of innovative dental care products aimed at preventing and treating dental diseases. The company focuses on tooth regeneration and offers solutions for various dental issues, including hypersensitivity, caries lesions, and damage from bleaching. Its product lineup includes Curodont Repair, Curodont Protect, and Curodont D’Senz, which help protect and regenerate enamel and dentin, providing dentists with effective tools to enhance oral health. By addressing problems such as acid erosion and white spot lesions, Credentis aims to improve patient outcomes and promote overall dental well-being.

Viroblock is a Swiss company dedicated to creating advanced antiviral technology that is both rapid-acting and broad-spectrum. The company's innovative approach involves a unique mechanism of action that effectively inactivates enveloped viruses, including those responsible for human and avian influenza, SARS, and AIDS. Viroblock's technology can be applied to non-woven fabrics, making it particularly effective for air filtration products. In standardized aerobiology tests, Viroblock fabric has demonstrated the ability to eliminate over 99% of H5N1 viruses. This combination of capabilities positions Viroblock as a leader in the development of antiviral products that do not promote viral resistance, offering significant advancements in the treatment and prevention of viral diseases.

Advanced Osteotomy Tools AG is a Swiss company focused on developing innovative medical devices for osteotomy, a surgical procedure that involves cutting and reshaping bones. Established in 2010 and based in Basel, the company specializes in a computer-assisted and robot-guided laser osteotome device designed for precise functional geometrical bone cuts. This technology is applicable in cranio-maxillofacial interventions and various complex surgical procedures. Advanced Osteotomy Tools AG originated from the University Hospital and the University of Basel, transitioning into a privately owned entity in 2011, with its first funding secured in 2012. The company's mission is to advance bone surgery by utilizing laser technology, robotics, and navigation systems for a contact-free surgical experience.

VirtaMed AG, founded in 2007 and headquartered in Schlieren, Switzerland, specializes in developing high-fidelity surgical simulators for medical training. The company offers a range of simulators focused on fields such as orthopedics, obstetrics and gynecology, laparoscopy, and urology, as well as custom-made solutions. By integrating advanced simulation technology and data analytics into medical education, VirtaMed aims to enhance the proficiency of surgeons and improve surgical training programs. Their products provide a realistic training experience with progressively complex scenarios, guided by competency-based curricula endorsed by medical societies. This approach not only helps prepare trainees for real-world surgical procedures but also reduces reliance on disposable materials during training, ultimately accelerating the path to surgical competency. With a global network of partnerships, VirtaMed is committed to advancing surgical excellence for all patients.